Valuation: Vitrolife AB

Market Cap 12.05B 1.27B 1.1B 1.03B 939M 1.77B 121B 1.8B 4.73B 60.61B 4.77B 4.67B 202B P/E 2026 *
24.5x
P/E 2027 * 19.8x
Enterprise Value 12.6B 1.33B 1.15B 1.07B 982M 1.85B 127B 1.88B 4.94B 63.37B 4.99B 4.88B 211B EV / Sales 2026 *
3.64x
EV / Sales 2027 * 3.24x
Free-Float
54.39%
Yield 2026 *
1.24%
Yield 2027 * 1.42%
1 day+1.01%
1 week-0.11%
Current month+4.30%
1 month+1.87%
3 months-17.24%
6 months+4.78%
Current year-34.45%
1 week 88.05
Extreme 88.05
91.8
1 month 84
Extreme 84
101.9
Current year 84
Extreme 84
139.6
1 year 84
Extreme 84
153.5
3 years 84
Extreme 84
268
5 years 84
Extreme 84
585
10 years 70
Extreme 70
585
Manager TitleAgeSince
Chief Executive Officer 52 31/07/2023
Director of Finance/CFO 55 09/10/2025
Chief Investment Officer 40 -
Director TitleAgeSince
Director/Board Member 63 18/04/2013
Chairman 70 31/07/2023
Chairman 55 -
Date Insider Type Main position Quantity % Market Cap.
06/02/26 Buy

Chief Operating Officer

6,470 0.0048%
06/02/26 Buy

Chief Executive Officer

3,013 0.0022%
04/02/26 Buy

Chief Financial Officer

2,200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+1.01%-0.11%-33.48%-41.76% 1.27B
-0.75%+5.28%+208.33%+363.44% 22.44B
-0.20%+0.76%-41.29%-22.13% 9.97B
+12.57%+24.59%+376.57%+12.83% 7.63B
+2.90%+43.38%-21.34% - 6.61B
+0.03%-0.21%+76.54%+48.30% 6.59B
+1.51%+2.23%-10.99%-12.48% 5.71B
-0.47%+11.80%+82.30%+104.76% 4.49B
-0.18%+2.20%-7.69%-16.79% 4.36B
+1.30%-3.86%-19.78%-35.33% 2.78B
Average +1.77%+58.11%+60.92%+44.54% 7.19B
Weighted average by Cap. +1.49%+84.36%+106.83%+130.68%

Financials

2026 *2027 *
Net sales 3.46B 364M 315M 295M 269M 508M 34.75B 516M 1.36B 17.39B 1.37B 1.34B 57.91B 3.71B 391M 338M 316M 289M 544M 37.26B 553M 1.45B 18.64B 1.47B 1.44B 62.09B
Net income 493M 51.91M 44.93M 42M 38.39M 72.34M 4.95B 73.47M 193M 2.48B 195M 191M 8.25B 609M 64.15M 55.54M 51.91M 47.44M 89.41M 6.12B 90.8M 239M 3.06B 241M 236M 10.19B
Net Debt 549M 57.86M 50.09M 46.82M 42.79M 80.64M 5.52B 81.9M 215M 2.76B 217M 213M 9.2B -26.74M -2.82M -2.44M -2.28M -2.08M -3.93M -269M -3.99M -10.49M -134M -10.58M -10.35M -448M
Logo Vitrolife AB
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
Employees
1,103
Date Price Change Volume
11/08/26 SEK 89.80 +0.90% 10,884
10/08/26 SEK 89.00 -1.11% 95,705
07/08/26 SEK 90.00 +1.35% 2,406,853
06/08/26 SEK 88.80 +0.85% 177,458
05/08/26 SEK 88.05 -2.06% 175,665
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
89.00SEK
Average target price
129.60SEK
Spread / Average Target
+45.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VITR Stock